AegirBio AB (52Q) Stock Statistics & Valuation Metrics

AegirBio AB has a market cap or net worth of €14.84M. The enterprise value is €48.93M.

AegirBio AB has 1,991,861,800 shares outstanding. The number of shares has decreased by -2.65% in one year.

AegirBio AB’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of AegirBio AB is ―. AegirBio AB’s PEG ratio is ―.

In the last 12 months, AegirBio AB had revenue of ― and earned -92.33M in profits. Earnings per share was ―.

In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.

AegirBio AB pays an annual dividend of ―, resulting in a dividend yield of ―

AegirBio AB upcoming earnings date is May 21, 2025, TBA Not Confirmed.

AegirBio AB as a current ratio of ―, with Debt / Equity ratio of ―

In the past 12 months, AegirBio AB has paid ― in taxes.

AegirBio AB EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

AegirBio AB has ― in cash and marketable securities with 0.00 in debt, giving a net cash position of ― billion.

Gross margin is ―, with operating margin of ―, and net profit margin of ―.

The average price target for AegirBio AB is ―, which is 11.43% higher than the current price. The consensus rating is ―